A new mechanism for transmissible prion diseases

Journal of Neuroscience

Volumn 32, Issue 21, 2012, Pages 7345-7355

  Makarava, Natallia ^a   Kovacs, Gabor G ^b   Savtchenko, Regina ^a   Alexeeva, Irina ^a   Ostapchenko, Valeriy G ^a,c   Budka, Herbert ^b   Rohwer, Robert G ^a   Baskakov, Ilia V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN; PROTEINASE K; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA SHEET; BIOASSAY; CONTROLLED STUDY; DEGLYCOSYLATION; ELECTRON MICROSCOPY; HISTOPATHOLOGY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STABILITY; SYRIAN HAMSTER; WESTERN BLOTTING;

AMYLOID; ANIMALS; BRAIN; CRICETINAE; ENDOPEPTIDASE K; MALE; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PROTEIN FOLDING; RECOMBINANT PROTEINS;

EID: 84861309020     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6351-11.2012     Document Type: Article

References (44)

1. Aguzzi A, Rajendran L (2009) The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64:783-790.
2. Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, Bartz JC (2011) The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog 7:e1001317.
3. Baron T, Bencsik A, Vulin J, Biacabe AG, Morignat E, Verchere J, Betemps D (2008) A C-terminal protease-resistant prion fragment distinguishes ovine "CH1641-like" scrapie from bovine classical and L-type BSE in ovine transgenic mice. PLoS Pathog 4:e1000137.
4. Baskakov IV, Breydo L (2007) Converting the prion protein: What makes the protein infectious. Biochim Biophys Acta 1772:692-703.
5. Biacabe AG, Jacobs JG, Bencsik A, Langeveld JP, Baron TG (2007) H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases. Prion 1:61-68.
6. Bocharova OV, Breydo L, Parfenov AS, Salnikov VV, Baskakov IV (2005a) In vitro conversion of full length mammalian prion protein produces amyloid form with physical property of PrPSc. J Mol Biol 346:645-659.
7. Sc. Protein Sci 14:1222-1232.
8. Bruce ME, Dickinson AG (1987) Biological evidence that the scrapie agent has an independent genome. J Gen Virol 68:79-89.
9. Cohen FE, Prusiner SB (1998) Pathologic conformations of prion proteins. Annu Rev Biochem 67:793-819.
10. Colby DW, Giles K, Legname G, Wille H, Baskakov IV, DeArmond SJ, Prusiner SB (2009) Design and construction of diverse mammalian prion strains. Proc Acad Natl Sci U S A 106:20417-20422.
11. Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO, Lemus A, Cohen FE, DeArmond SJ, Prusiner SB (2010) Proteasesensitive synthetic prions. PLoS Pathog 6:e1000736.
12. Comoy EE, Casalone C, Lescoutra-Etchegaray N, Zanusso G, Freire S, Marcé D, Auvré F, Ruchoux MM, Ferrari S, Monaco S, Salès N, Caramelli M, Leboulch P, Brown P, Lasmézas CI, Deslys JP (2008) Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS One 3:e3017.
13. DeArmond SJ, Qiu Y, Sánchez H, Spilman PR, Ninchak-Casey A, Alonso D, Daggett V (1999) PrP C glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol 58:1000-1009.
14. Deleault AM, Deleault NR, Harris BT, Rees JR, Supattapone S (2008) The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol 89:2642-2650.
15. Deleault NR, Lucassen RW, Supattapone S (2003) RNAmolecules stimulate prion protein conversion. Nature 425:717-720.
16. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S (2005) Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 280:26873-26879.
17. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Acad Natl Sci U S A 104:9741-9746.
18. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S (2010) Speciesdependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49:3928-3934.
19. Frost B, Diamond MI (2010) Prion-like mechanisms on neurodegenerative diseases. Nat Rev Neurosci 11:155-159.
20. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenko R, Alexeeva I, Rohwer RG, Baskakov IV (2011a) Highly Efficient Protein Misfolding Cyclic Amplification. PLoS Pathogen 7:e1001277.
21. Gonzalez-Montalban N, Makarava N, Savtchenko R, Baskakov IV (2011b) Relationship between conformational stability and amplification efficiency of prions. Biochemistry 50:7933-7940.
22. Jackson WS, Borkowski AW, Faas H, Steele AD, King OD, Watson N, Jasanoff A, Lindquist S (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63:438-450.
23. Kong Q, Surewicz WK, Petersen RB, Zou W, Chen SG, Gambetti P, Parchi P, Capellari S, Goldfarb L, Montagna P, Lugaresi E, Piccardo P, Ghetti B (2004) Inherited prion diseases. In: Prion biology and diseases (Prusiner SB, ed), pp 673-775. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
24. Legname G, Nguyen H-OB, Baskakov IV, Cohen FE, DeArmond SJ, Prusiner SB (2005) Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A 102:2168-2173.
25. Makarava N, Baskakov IV (2008) The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem 283:15988-15996.
26. Makarava N, Ostapchenko VG, Savtchenko R, Baskakov IV (2009) Conformational switching within individual amyloid fibrils. J Biol Chem 284:14386-14395.
27. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV (2010) Recombinant prion protein induces a new transmissible prion disease in wild type animals. Acta Neuropathol 119:177-187.
28. Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV (2011) Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog 7:e1002419.
29. Makarava N, Savtchenko R, Alexeeva I, Rohwer RG, Baskakov IV (2012) Fast and ultrasensitive method for quantitating prion infectivity titer. Nat Commun 3:741.
30. Miller G (2009) Could they all be prion diseases? Science 326:1337-1339.
31. Monnet C, Marthiens V, Enslen H, Frobert Y, Sobel A, Mège RM (2003) Heterogeneity and regulation of cellular prion protein glycoforms in neuronal cell lines. Eur J Neurosci 18:542-548.
32. Ostapchenko VG, Sawaya MR, Makarava N, Savtchenko R, Nilsson KP, Eisenberg D, Baskakov IV (2010) Two amyloid states of the prion protein display significantly different folding patterns. J Mol Biol 400:908-921.
33. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527-529.
34. Piro JR, Wang F, Walsh DJ, Rees JR, Ma J, Supattapone S (2011) Seeding specificity and ultrastructural characteristics of infectious recombinant pPrions. Biochemistry 50:7111-7116.
35. Prusiner SB (1997) Prion diseases and the BSE crisis. Science 278:245-251.
36. Prusiner SB, Scott MR (1997) Genetics of prions. Annu Rev Genet 31:139-175.
37. Russelakis-Carneiro M, Saborio GP, Anderes L, Soto C (2002) Changes in the glycosylation pattern of prion protein in murine scrapie. J Biol Chem 277:36872-36877.
38. Saá P, Castilla J, Soto C (2006) Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 281:35245-35252.
39. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwartz P, Ott D, Rulicke T, Liberski T, Julius C, Falsiq J, Stitz L, Wuthrich K, Aguzzi A (2009) De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Acad Natl Sci U S A 106:304-309.
40. Spassov S, Beekes M, Naumann D (2006) Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim Biophys Acta 1760:1138-1149.
41. Sun Y, Makarava N, Lee CI, Laksanalamai P, Robb FT, Baskakov IV (2008) Conformational stability of PrP amyloid firbils controls their smallest possible fragment size. J Mol Biol 376:1155-1167.
42. Wang F, Wang X, Yuan CG, Ma J (2010) Generating a Prion Bacterially Expressed Recombinant Prion Protein. Science 327:1132-1135.
43. Wille H, Bian W, McDonald M, Kendall A, Colby DW, Bloch L, Ollesch J, Borovinskiy AL, Cohen FE, Prusiner SB, Stubbs G (2009) Natural and synthetic prion structure from X-ray fiber diffraction. Proc Acad Natl Sci U S A 106:16990-16995.
44. Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 278:40429-40436.